The effect of antioxidant supplementation on superoxide dismutase activity, Cu and Zn levels, and total antioxidant status in erythrocytes of patients with Graves' disease

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 4, 2005, Pages 383-388

  Bacic Vrca, Vesna ^a,b   Skreb, Franjo ^b   Cepelak, Ivana ^a   Mayer, Ljiljana ^b   Kusic, Zvonko ^c   Petres, Blanka ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b University of Zagreb School of Medicine   (Croatia)

^c SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^d Croatia   (Croatia)

Author keywords

Antioxidants; Copper; Graves' disease; Superoxide dismutase; Total antioxidant status; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; ATHYRAZOL; BETA CAROTENE; COPPER; SELENIUM; SUPEROXIDE DISMUTASE; SYMBION; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; ZINC; ANTITHYROID AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ERYTHROCYTE; EUTHYROIDISM; FEMALE; GRAVES DISEASE; HUMAN; HUMAN CELL; MALE; MONITORING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; ADOLESCENT; BLOOD; CHEMISTRY; DIET SUPPLEMENTATION; DRUG COMBINATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; ANTITHYROID AGENTS; COPPER; DIETARY SUPPLEMENTS; DRUG COMBINATIONS; ENZYME ACTIVATION; ERYTHROCYTES; FEMALE; GRAVES DISEASE; HUMANS; MALE; METHIMAZOLE; MIDDLE AGED; SUPEROXIDE DISMUTASE; THYROID HORMONES; THYROTROPIN; ZINC;

EID: 24044522590     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.069     Document Type: Article

References (28)

1. Mano T, Shinohra R, Sawai Y, Oda N, Nishida T, Mokuno T, et al. Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle. J Endocrinol 1995;145:131-6.
2. Carrion Y, Fernandez V, Videla LA. Influence of thyroid hormone administration on hepatic glutathione content and basolateral γ-glutamyltransferase ectoactivity in the isolated perfused rat liver. Biochem Pharmacol 1993; 45:2527-35.
3. Fernandez V, Simizu K, Barros SB. Effects of hyperthyroidism on rat liver glutathione metabolism: related enzyme activities, efflux, and turnover. Endocrinology 1991;129:85-91.
4. Fernandez V, Barrientos X, Kipreos K, Valenzuela A, Videla LA. Superoxide radical generation, NADPH oxidase activity and cytochrome P-450 content of rat liver microsomal fraction in experimental hyperthyroid state: relation to lipid peroxidation. Endocrinology 1985;117:496-501.
5. Mano T, Iwase K, Hayashi R, Hayakawa N, Uchimura K, Makino M, et al. Vitamin E and coenzyme Q concentrations in the thyroid tissue of patients with various thyroid disorders. Am J Med Sci 1998;315:230-2.
6. Iwase K, Nagasaka A, Kato K, Ohtani S, Tsujimura T, Inagaki A, et al. Localization of Cu/Zn superoxide dismutase in various thyroid disorders. Acta Endocrinol 1993; 129:573-8.
7. Ozdem S, Alicigüzel Y, Ozdem SS, Karayalcin U. Effects of propylthiouracil treatment on antioxidant activities in blood of toxic multinodular goiter patients. Pharmacology 2000;61:31-6.
8. Komosinska-Vassev K, Olczyk K, Kucharz EJ, Marcisz C, Winsz-Szczotka K, Kotulska A. Free radical activity and antioxidant defense mechanisms in patients with hyperthyroidism due to Graves' disease during therapy. Clin Chim Acta 2000;300:107-17.
9. Seven A, Seymen O, Hatemi S, Hatemi H, Yigit G, Candan G. Antioxidant status in experimental hyperthyroidism: effect of vitamin E supplementation. Clin Chim Acta 1996;256:65-74.
10. Seven A, Tasan E, Inci F, Hatemi H, Burcak G. Biochemical evaluation of oxidative stress in propylthiouracil-treated hyperthyroid patients. Effects of vitamin C supplementation. Clin Chem Lab Med 1998;36:767-70.
11. Adali M, Inal-Erden M, Akalin A, Efe B. Effects of propylthiouracil, propranolol, and vitamin E on lipid peroxidation and antioxidant status in hyperthyroid patients. Clin Biochem 1999;32:363-7.
12. Guerra LN, Moiguer S, Karner M, De Molina MCR, Sreider CM, Burdman JA. Antioxidants in the treatment of Graves' disease. Life 2001;51:105-9.
13. Vrca VB, Skreb F, Cepelak I, Romic Z, Mayer L. Supplementation with antioxidants in the treatment of Graves' disease: the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 2004; 341:55-63.
14. Masiukiewicz US, Burrow GN. Hyperthyroidism in pregnancy: diagnosis and treatment. Thyroid 1999;9:647-52.
15. Koshiyama H, Sellitti DF, Akamizu T, Doi SQ, Takeuchi Y, Inoue D, et al. Cardiomyopathy associated with Graves' disease. Clin Endocrinol 1996;45:111-6.
16. Chaurasia SS, Kar A. Protective effects of vitamin E against lead-induced deterioration of membrane associated type-I iodothyronine monodeiodinase (5′D-I) activity in male mice. Toxicology 1997;124:203-9.
17. Brzezinska-Slebodinzska E. Fever-induced oxidative stress: the effect on thyroid status at the 5′-monodeiodinase activity; protective role of selenium and vitamin E. J Physiol Pharmacol 2001;52:275-84.
18. Nordberg J, Arner ES. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001;31:1287-312.
19. Frei B, Stocker R, England L, Ames BN. Ascorbate: the most effective antioxidant in human blood plasma. Adv Exp Med Biol 1990;264:155-63.
20. Shull S, Heintz NH, Periasamy M, Manohar M, Janssen YM, Marsh JP, et al. Differential regulation of antioxidant enzymes in response to oxidants. J Biol Chem 1991;266:24398-403.
21. Tainer JA, Getzoff ED, Richardson JS, Richardson DC. Structure and mechanism of copper, zinc superoxide dismutase. Nature 1983;306:284-7.
22. Aihara K, Nishi Y, Hatano S, Kihara M, Yoshimitsu K, Takeichi N, et al. Zinc, copper, manganese, and selenium metabolism in thyroid disease. Am J Clin Nutr 1984;40:26-35.
23. Taniguchi N, Ishikawa N, Kondo T. Inhibitory effect of thyroxine on carbonic anhydrase B isozyme biosynthesis in rabbit reticulocyte lysates. Biochem Biophys Res Commun 1978;85:952-8.
24. Liu N, Liu P, Xu Q, Zhu L, Zhao Z, Wang Z, et al. Elements in erythrocytes of population with different thyroid hormone status. Biol Trace Elem Res 2001;84:37-43.
25. Sayama N, Yoshida K, Mori K, Fukazawa H, Hori H, Nakazato N, et al. Measurement of red blood cell zinc concentration with Zn-test kit: discrimination between hyperthyroid Graves' disease and transient thyrotoxicosis. Endocr J 1998;45:767-72.
26. Yoshida K, Kiso Y, Watanabe TK, Kaise K, Itagaki Y, Yamamoto M, et al. Erythrocyte zinc in hyperthyroidism: reflection of integrated thyroid hormone levels over the previous few months. Metabolism 1990;39:182-6.
27. Abuja PM, Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin Chim Acta 2001;306:1-17.
28. Vrca VB, Skreb F, Cepelak I, Mayer Lj. Supplementation with antioxidants in the treatment of Graves' disease: the effect on the extracellular antioxidative parameters. Acta Pharm 2004;54:79-89.